All 19
patients in the study achieved some degree of remission after three months of treatment.
«This analysis shows that MRD - directed therapy clearly contributed to the unprecedented high rates of long - term survival that
patients in this study achieved,» said first and corresponding author Ching - Hon Pui, M.D., chair of the St.Jude Department of Oncology.
Not exact matches
These risks and uncertainties include: Gilead's ability to
achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror
patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured
patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and
patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical
studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Additional data from this
study, also presented at The International Liver CongressTM today
in Barcelona, Spain, show that 97 % of
patients with the same HCV genotype, but without scarred livers,
achieved SVR12 after eight weeks on the same treatment without ribavirin (RBV).
In addition, even after hospitals achieved a volume of 100 or so cases, there continued to be improvement in patient outcomes with higher procedure volume,» said John D. Carroll, M.D., professor of medicine and director of interventional cardiology at the University of Colorado Hospital and lead author of the stud
In addition, even after hospitals
achieved a volume of 100 or so cases, there continued to be improvement
in patient outcomes with higher procedure volume,» said John D. Carroll, M.D., professor of medicine and director of interventional cardiology at the University of Colorado Hospital and lead author of the stud
in patient outcomes with higher procedure volume,» said John D. Carroll, M.D., professor of medicine and director of interventional cardiology at the University of Colorado Hospital and lead author of the
study.
Results presented today at The International Liver Congress ™ 2015 demonstrate that hepatitis C (HCV)- infected genotype - 3 (GT - 3)
patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF)
in combination with ribavirin (RBV) and peginterferon (PEG)
achieved the highest sustained virologic response rates at 12 weeks (SVR12), observed
in a Phase 3
study, to date.
The grant was to
study what types of computational systems,
in conjunction with physiological
patient monitors, could be implemented into vehicles to
achieve the safety objective.
In a single case study of one patient they achieved 36 % improvement in hand motor function in just 10 training sessions of 30 minutes eac
In a single case
study of one
patient they
achieved 36 % improvement
in hand motor function in just 10 training sessions of 30 minutes eac
in hand motor function
in just 10 training sessions of 30 minutes eac
in just 10 training sessions of 30 minutes each.
In two studies appearing in the May 5 issue of JAMA, patients with chronic hepatitis C virus (HCV) genotype 1 infection and with or without cirrhosis achieved high rates of sustained virologic response after 12 weeks of treatment with a combination of the direct - acting - antiviral drugs daclatasvir, asunaprevir, and beclabuvi
In two
studies appearing
in the May 5 issue of JAMA, patients with chronic hepatitis C virus (HCV) genotype 1 infection and with or without cirrhosis achieved high rates of sustained virologic response after 12 weeks of treatment with a combination of the direct - acting - antiviral drugs daclatasvir, asunaprevir, and beclabuvi
in the May 5 issue of JAMA,
patients with chronic hepatitis C virus (HCV) genotype 1 infection and with or without cirrhosis
achieved high rates of sustained virologic response after 12 weeks of treatment with a combination of the direct - acting - antiviral drugs daclatasvir, asunaprevir, and beclabuvir.
Elaine Mardis:
In 2013 there were numerous
studies [that provide] growing evidence that linking a
patient's tumor genotype to a drug or drugs can
achieve at least temporary remission.
In addition, many patients in the study required more than one ablation procedure to achieve freedom from atrial fibrillatio
In addition, many
patients in the study required more than one ablation procedure to achieve freedom from atrial fibrillatio
in the
study required more than one ablation procedure to
achieve freedom from atrial fibrillation.
The
study results suggest that while training doesn't change neurological repair
in chronic stroke
patients, it can indeed help such
patients learn new motor skills and
achieve more independence
in their daily lives.
«What makes these results especially encouraging is that they were
achieved in patients who had exhausted other treatment options,» said the
study's co-senior author, Margaret Shipp, MD, chief, Division of Hematologic Neoplasia at Dana - Farber.
Studies show that PD - 1 inhibitors are effective for a larger proportion of melanoma
patients than ipilimumab alone — and,
in combination with that drug, they
achieve a two - year survival rate of 80 percent.
Among the evaluable
patients in the newly reported phase II
study, 23 (58 %)
achieved complete response to the combination within four cycles, and 6 (15 %) had a partial response.
Rao, together with senior author Michael Brenner, set out to explore these questions by
studying patient samples
in remarkable detail not
achieved in earlier
studies.
«These
studies provide promising evidence that autophagy blockade can be
achieved, and that combining autophagy inhibitors with other cancer therapies
in very sick
patients can be accomplished safely
in most cases.
In an Arthritis Care & Research study, Susan Goodman, MD, of the Hospital for Special Surgery and Weill Cornell Medical School, and her colleagues investigated the potential impact of weight on the likelihood that patients would achieve remission in the early years after an RA diagnosi
In an Arthritis Care & Research
study, Susan Goodman, MD, of the Hospital for Special Surgery and Weill Cornell Medical School, and her colleagues investigated the potential impact of weight on the likelihood that
patients would
achieve remission
in the early years after an RA diagnosi
in the early years after an RA diagnosis.
If findings can be validated across multiple
studies that are free of these limitations, then this approach could enable safe discharge of many more
patients than is
achieved in current practice.
In this study, researchers demonstrated that continued HIV replication in lymphoid tissue sanctuaries refills viral reservoirs in patients on ART who have achieved undetectable blood levels of HI
In this
study, researchers demonstrated that continued HIV replication
in lymphoid tissue sanctuaries refills viral reservoirs in patients on ART who have achieved undetectable blood levels of HI
in lymphoid tissue sanctuaries refills viral reservoirs
in patients on ART who have achieved undetectable blood levels of HI
in patients on ART who have
achieved undetectable blood levels of HIV.
The Aging Brain Care Medical Home, a novel population health management program implemented
in the homes of older adults
achieves significant health improvement for individuals with depression and also substantial stress reduction
in family caregivers of dementia
patients, according to a new
study by investigators from the Regenstrief Institute, Indiana University Center for Aging Research and Eskenazi Health.
«Personalized cellular therapy
achieves complete remission
in 90 percent of acute lymphoblastic leukemia
patients studied.»
Despite the allocation of all
patients in this
study to specific treatment, 48 of the 210 ongoing pregnancies (23 %) were
achieved by natural conception.
The two ALS
patients achieved 2.2 and 1.4 bits per second, respectively, more than doubling previous records (held by these same participants
in a previous
study from this group).
In fact, ACOs achieved meaningful improvements for patients in some key areas,» said lead author of the study J. Michael McWilliams, associate professor of health care policy and medicine at HMS and Brigham and Women's Hospita
In fact, ACOs
achieved meaningful improvements for
patients in some key areas,» said lead author of the study J. Michael McWilliams, associate professor of health care policy and medicine at HMS and Brigham and Women's Hospita
in some key areas,» said lead author of the
study J. Michael McWilliams, associate professor of health care policy and medicine at HMS and Brigham and Women's Hospital.
In the
study of HBeAg - negative
patients, 94 % (268 of 285) of
patients receiving TAF and almost 93 % (130 of 140) of
patients receiving TDF
achieved the primary endpoint.
In the
study of HBeAg - positive
patients, almost 64 % (371 of 581) of
patients receiving TAF and almost 67 % (195 of 292) of
patients receiving TDF
achieved the primary endpoint.
Study participation was restricted to
patients with either ventricular fibrillation or ventricular tachycardia who did not
achieve a stable heart rhythm after at least one defibrillator shock and, therefore, represent the typical group of those who receive such medications for cardiac arrest
in clinical practice.
In this Phase 2a
study, significantly more guselkumab - treated
patients achieved ACR 20/50/70 responses and Psoriasis Area Severity Index (PASI) 75/90/100 responses at week 24.
A recent
study by Drs. Thaler, O'Malley, Weinstein and other colleagues at Penn found that the TORS approach
achieved a significant reduction
in the apnea - hypopnea index (AHI)(an index used to assess the severity of sleep apnea), a significant improvement
in minimum arterial oxygen saturation (the amount of oxygen
in your blood that maintains healthy organ functioning), and a significant improvement
in daytime drowsiness
in patients.
«Our
study shows that genotyping of CYP2C19 could be of considerable clinical value
in individualising doses of escitalopram so that a better all - round antidepressive effect could be
achieved for the
patients,» says Professor Magnus Ingelman - Sundberg at Karolinska Institutet's Department of Physiology and Pharmacology who led the
study together with Professor Espen Molden.
Of 24
patients who
achieve complete response
in this
study, plus the 20
patients reported previously by our group, only two have developed recurrent melanoma at 19 and 27 months with a median potential follow - up of 53.4 months.»
Citing
studies in cities where many more runs were canceled en route rather than resulting
in treatment of
patients, two academic physicians writing
in the journal Neurology concluded it could be a «tall order» for MSUs to
achieve a return on investment for individual health systems and communities.
(15) Another
study reported benefit on overall symptoms scores, with 88 % of
patients reported as
achieving «mild - to - excellent improvement
in IBS symptoms».
It is at present unknown whether an optimal balance between safety and efficacy can be
achieved with the combination therapy of GH and IGF - I, since this combination has been evaluated
in only a small number of
patient populations and
in studies of a relatively short duration.
In a recent trial for ulcerative colitis, a multicenter, randomized, placebo - controlled, double - blind
study found that more than 50 percent of
patients achieved remission within just one month on curcumin compared to none of the
patients who received the placebo.
However, the effects of dietary fiber on glycemic control were considered inconsequential.1 Furthermore, the expert panel of the ADA considered it difficult to
achieve a high dietary intake of soluble fiber without consuming foods or supplements fortified with fiber.1 We therefore designed the present
study to determine the effects on glycemic control and plasma lipid concentrations of increasing the intake of dietary fiber
in patients with type 2 diabetes exclusively through the consumption of foods not fortified with fiber (unfortified foods) to a level beyond that recommended by the ADA.
It is interesting that the significant weight loss using the intervention
in this
study was primarily seen
in patients taking insulin, based on post hoc analyses, as it is notoriously difficult to
achieve weight loss
in patients using this anabolic hormone.
The herb hasn't proved effective
in studies with canine cancer
patients — it seems the doses given weren't enough to
achieve the blood levels required to make an impact on the disease.
Social Service Specialist — Duties & Responsibilities Trained
in social service with a focus on crisis intervention, rehabilitation, public safety and criminal justice Oversee mediation, life skills, and practical guidance for clients facing personal challenges Set client goals and provide benchmarks and action plans for
achieving success Coordinate confidential
patient information
in an accessible and organized fashion Provide administrative support services across a variety of human services settings Represent company brand with poise, integrity, and positivity Responsible for client and staff schedules ensuring timely and efficient daily operations Set and strictly adhere to all department budgets and project timelines Handle accounts receivable, accounts payable, QuickBooks, billing, and reimbursements Responsible for tracking and replenishing office supplies
Study internal literature to become an expert on products and services Develop and strengthen relationships with partner agencies, coworkers, and community leaders Train new team members ensuring they understand the brand and adhere to company policies and procedures Perform all duties with positivity, integrity, and professionalism
Both the YPIC
study and the adult Partners -
in - Care
Study52
achieved a roughly 10 percentage - point difference
in the percentage of
patients falling
in the clinically significant range on the CES - D as well as
achieving clinically meaningful improvements
in mental health - related quality of life.
Over the years I have
studied and trained
in a number of modalities that can be integrated to help my
patients achieve emotional, mental and physical balance.
The following hypotheses were tested: that the cognitive behaviour therapy would be superior to supportive counselling and routine care, and routine care alone, firstly,
in reducing positive psychotic symptoms; secondly,
in preventing the exacerbation of positive symptoms and reducing hospital stay; and, thirdly, by using the convention of the previous
study of 50 % improvement
in positive symptoms as an indicator of considerable clinical improvement, 6
in the number of
patients achieving such improvement.
The aims of the analyses presented
in this
study were 1) to explore possible associations between the coping resources with
achieved copying behaviors,... quality of life, pain - related factors and socio - demographic characteristics and 2) to identify
patients with back pain who use different coping resources and to describe their respective socio - demographic and clinical characteristics.
The objective of this
study was to determine if
patients with diagnosed stage - 1 hypertension could benefit by a forgiveness training program to
achieve measurable reductions
in anger expression and blood pressure.